Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 20, 2015
The contract development and manufacturing organisation, Recipharm AB has entered into an agreement whereby it will acquire a majority stake in Nitin Lifesciences Limited, an Indian sterile injectables CMO, currently owned by the Sobti family.
read more
Thursday, November 09, 2017
Recipharm will initiate a process with the intention of discontinuing manufacturing operations at its facilities in Stockholm and Höganäs, Sweden.
read more
Recipharm is expanding its pMDI product development expertise to accommodate the increasing demand from pharmaceutical companies as they begin the transition to the next generation of propellants over the coming years. These new propellant gases have...
read more
Recipharm, the contract development and manufacturing organization (CDMO), has announced a 5 million SEK investment into a new GLP (Good Laboratory Practice) compliant bioanalysis laboratory at its development facility in Uppsala, Sweden, in response...
read more
Thursday, December 20, 2018
Recipharm announced that it will explore the discontinuance of operations at its solid dose manufacturing facility in Ashton-under-Lyne, UK.
read more
Tuesday, September 17, 2024
Recipharm announced a significant investment in its Oral Solid Development and Pilot Scale Centre in Zwickau, Germany. The investment includes three new GMP Pilot Scale suites for blending, tableting and hard capsule filling, which will complement ...
read more
Recipharm has signed a licensing agreement with Altus Formulation to allow its customers to access new drug delivery technologies and products.
read more
Thursday, September 24, 2026
Recipharm and CanVirex have begun a manufacturing-development collaboration to scale production of CanVirex’s oncolytic measles virus platform for potential clinical studies in advanced solid tumors.
read more
Wednesday, November 13, 2019
Recipharm and CTC Clinical Trial Consultants have expanded their partnership with the divestment of Recipharm’s GLP bioanalysis business to the Center for Translational Research group.
read more
Tuesday, September 12, 2017
Recipharm and Clinical Trial Consultants have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestones.
read more
Recipharm has partnered with Hadasit Medical Research Services and Development to offer combined clinical, biological and chemical services.
read more
Thursday, September 14, 2017
Recipharm and Kancera have signed a contract for the development and manufacture of the pharmaceutical candidate KAND567.
read more
Recipharm and LIDDS have set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm in Solna, Sweden.
read more
Recipharm announced an exclusive licence and collaboration agreement with Medspray and Resyca, to develop soft mist nasal delivery devices for single and combination drug products.
read more
U-Protein Express announced the availability of its new recombinant SARS-CoV-2 proteins, and other proteins associated with COVID-19, for use by researchers globally.
read more